Sfoglia per RIVISTA
AMERICAN JOURNAL OF HEMATOLOGY
Collezione AO Ordine Mauriziano

  

Items : 6

First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies. in American journal of hematology

2024
AOU Città della Salute di Torino
AO Ordine Mauriziano

Laurenti L; Ferrero S; Zamprogna G; Hohaus S; Frustaci AM; Piazza F; Peri V; Noto A; Scapinello G; Musto P; Pasquale R; Petrilli D; Stirparo L; Fresa A; Innocenti I; Rossini B; Motta M; Bullo M; Marino D; Ferrarini I; Puccini B; Cencini E; Olivieri J; Rizzi R; Danesin N; Mattiello V; Galli E; Tedeschi A; Benevolo G; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
ASL Città di Torino
ASL Torino 4
AO Cuneo
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
AOU Alessandria

Della Porta MG; Naldi I; Santini V; Turrini M; Giordano L; Finelli C; Pasini P; Tosi P; Tanasi I; Selleri C; Frigeni M; Sancetta R; Norata M; Marchetti M; Grimaldi D; Fianchi L; Galimberti S; Ferrara F; Di Veroli A; Di Bona E; Occhini U; Rivoli G; Bono R; Calvisi A; Castelli A; Nicolino B; Leuzzi L; Molteni A; Guarini A; et alii...

The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib. in American journal of hematology / Am J Hematol. 2017 Aug;92(8):797-805. doi: 10.1002/ajh.24774. Epub 2017 May 30.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino

Castagnetti F; Gugliotta G; Breccia M; Iurlo A; Levato L; Albano F; Vigneri P; Abruzzese E; Rossi G; Rupoli S; Cavazzini F; Martino B; Orlandi E; Pregno P; Annunziata M; Usala E; Tiribelli M; Sica S; Bonifacio M; Fava C; Gherlinzoni F; Bocchia M; Soverini S; Bochicchio MT; Cavo M; Giovanni M; Saglio G; Pane F; Baccarani M; et alii...

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study in American Journal of Hematology

2014
AOU Città della Salute di Torino
AO Ordine Mauriziano

Morabito F; Bringhen S; Larocca A; Wijermans P; Victoria Mateos M; Gimsing P; Mazzone C; Gottardi D; Omedè P; Zweegman S; José Lahuerta J; Zambello R; Musto P; Magarotto V; Schaafsma M; Oriol A; Juliusson G; Cerrato C; Catalano L; Gentile M; Isabel Turel A; Marina Liberati A; Cavalli M; Rossi D; Passera R; Rosso S; Beksac M; Cavo M; Waage A; et alii...

The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy in American Journal of Hematology

2013
AO Ordine Mauriziano

Rambaldi A; Boschini C; Gritti G; Delaini F; Oldani E; Rossi A; Barbui AM; Caracciolo D; Ladetto M; Gueli A; De Crescenzo A; Passera R; Devizzi L; Patti C; Gianni AM; Tarella C;

Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: Description of its use in high risk patients in American Journal of Hematology

2013
AOU Città della Salute di Torino
AO Ordine Mauriziano

Cignetti A; Ruella M; Elia A; Tassi V; Redoglia V; Gottardi D; Tarella C;